TCL Archive Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million. July 30, 2004
TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013
TCL Archive Wyngaarden List, Reportedly Six-Seven Names For NCI Director, Goes to White House This Week November 11, 1988
TCL Archive PR firm Ketchum serves two clients on Medicare issues: CMS and ASCO. HHS policy officials weren’t told about potential conflict, department spokesman says. September 24, 2004
